Adoptive T-cell therapy for pediatric cytomegalovirus-associated retinitis

Key Points TCRαβ + /CD19 + -depleted haploidentical HSCT was used to restore immunity in a pediatric patient with combined immunodeficiency syndrome. Posttransplant drug-resistant CMV retinitis was successfully treated with T cells expanded from a haploidentical HSCT donor.